We are live on ! Find out more
BGM

Burkehill Global Management Portfolio holdings

AUM $2.77B
1-Year Est. Return 65.75%
This Fund
S&P 500
This Quarter Est. Return
+18.92%
1 Year Est. Return
+65.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.77B
AUM Growth
+$753M
Cap. Flow
+$549M
Cap. Flow %
19.8%
Top 10 Hldgs %
56.59%
Holding
245
New
66
Increased
5
Reduced
13
Closed
72

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$637M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$179M
4
O icon
Realty Income
O
+$77.9M
5
AAPL icon
Apple
AAPL
+$77.2M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$133M
2
FANG icon
Diamondback Energy
FANG
+$132M
3
SNDK
Sandisk
SNDK
+$79.4M
4
NRG icon
NRG Energy
NRG
+$65.8M
5
GFS icon
GlobalFoundries
GFS
+$57.2M

Sector Composition

Rank Sector Weight
1 Industrials 34.25%
2 Communication Services 15.05%
3 Technology 13.39%
4 Real Estate 12.74%
5 Healthcare 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNTC icon
126
Benitec Biopharma
BNTC
$437M
$2.01M 0.07%
150,000
– –
AGRO icon
127
Adecoagro
AGRO
$1.77B
$1.91M 0.07%
200,000
– –
HTFL
128
Heartflow Inc
HTFL
$4.15B
$1.91M 0.07%
65,000
– –
CLDX icon
129
Celldex Therapeutics
CLDX
$3.07B
$1.86M 0.07%
+50,000
New +$1.61M
ERAS icon
130
Erasca
ERAS
$5.69B
$1.83M 0.07%
100,000
– –
LIFE
131
Ethos Technologies Inc
LIFE
$2.68B
$1.81M 0.07%
100,000
– –
KYTX icon
132
Kyverna Therapeutics
KYTX
$499M
$1.78M 0.06%
200,000
– –
RCUS icon
133
Arcus Biosciences
RCUS
$3.7B
$1.54M 0.06%
50,000
– –
CMPX icon
134
Compass Therapeutics
CMPX
$398M
$1.53M 0.06%
700,000
– –
IMTX icon
135
Immatics
IMTX
$1.44B
$1.52M 0.05%
150,000
– –
EIKN
136
Eikon Therapeutics
EIKN
$580M
$1.5M 0.05%
115,000
– –
IMRX icon
137
Immuneering
IMRX
$309M
$1.5M 0.05%
300,000
– –
INVX
138
Innovex International
INVX
$2.08B
$1.49M 0.05%
60,000
– –
BCAX
139
Bicara Therapeutics
BCAX
$1.57B
$1.48M 0.05%
50,000
-50,000
-50% -$1.12M
TNYA icon
140
Tenaya Therapeutics
TNYA
$149M
$1.48M 0.05%
2,000,000
– –
AXGN icon
141
Axogen
AXGN
$2.51B
$1.39M 0.05%
30,000
– –
CBIO
142
Crescent Biopharma
CBIO
$760M
$1.33M 0.05%
74,000
– –
ESPR
143
DELISTED
Esperion Therapeutics
ESPR
$1.26M 0.05%
400,000
– –
VRDN icon
144
Viridian Therapeutics
VRDN
$2.62B
$1.19M 0.04%
65,000
– –
ARX
145
Accelerant Holdings
ARX
$4.31B
$1.17M 0.04%
100,000
– –
OMDA
146
Omada Health Inc
OMDA
$1.36B
$1.1M 0.04%
50,000
– –
BRCB
147
Black Rock Coffee Bar Inc
BRCB
$212M
$1.04M 0.04%
125,000
– –
SUJA
148
Suja Life Inc
SUJA
$235M
$1.02M 0.04%
+100,000
New +$1.34M
ZBIO
149
Zenas BioPharma
ZBIO
$2.15B
$1.02M 0.04%
40,000
– –
ATAI icon
150
AtaiBeckley Inc
ATAI
$2.7B
$975K 0.04%
185,000
– –
4 5
6
7 8

Similar funds

C
Consulta London, United Kingdom $2.77B AUM 3.62% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.77B AUM 20.35% 1-Year Est. Return
JHP
James Hambro & Partners London, United Kingdom $2.76B AUM 19.67% 1-Year Est. Return
CAAS
Capital Asset Advisory Services Williamston, Michigan $2.76B AUM 18.08% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
CCM
Chickasaw Capital Management Memphis, Tennessee $2.78B AUM 20.87% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.78B AUM 23.76% 1-Year Est. Return

Burkehill Global Management's Q2 2026 Portfolio in Review

As of Q2 2026, Burkehill Global Management held 245 positions worth $2.77B, up 37% from $2.02B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Burkehill Global Management deployed $549M of net new capital in Q2 2026, opening 66 new positions and adding to 5 existing holdings. Its largest new stake was SpaceX: 3,750,000 shares worth $641M.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 19% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Galaxy Digital Inc, an estimated $33.4M trimmed.

  • Burkehill Global Management's largest Q2 2026 buy was SpaceX: 3,750,000 shares worth $641M.
  • Burkehill Global Management added most to SOLV Energy Inc in Q2 2026, an estimated $9.43M increase.
  • Burkehill Global Management's biggest Q2 2026 reduction was Galaxy Digital Inc, cutting an estimated $33.4M.
  • Burkehill Global Management fully exited Eli Lilly in Q2 2026, selling an estimated $133M.
  • Burkehill Global Management's ten largest holdings make up 57% of its $2.77B portfolio in Q2 2026.
  • Burkehill Global Management opened 66 new positions and closed 72 in Q2 2026.
  • Burkehill Global Management's portfolio value rose 37% quarter-over-quarter to $2.77B.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.